BioMaxima S.A. (WSE:BMX)
Poland flag Poland · Delayed Price · Currency is PLN
13.15
-0.10 (-0.75%)
Aug 14, 2025, 4:49 PM CET

BioMaxima Revenue

BioMaxima had revenue of 15.28M PLN in the quarter ending March 31, 2025, with 32.51% growth. This brings the company's revenue in the last twelve months to 56.60M, up 19.81% year-over-year. In the year 2024, BioMaxima had annual revenue of 52.85M with 12.96% growth.

Revenue (ttm)
56.60M
Revenue Growth
+19.81%
P/S Ratio
0.98
Revenue / Employee
449.21K
Employees
126
Market Cap
55.56M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202452.85M6.07M12.96%
Dec 31, 202346.79M-97.08M-67.48%
Dec 31, 2022143.87M64.78M81.91%
Dec 31, 202179.09M17.81M29.06%
Dec 31, 202061.28M30.67M100.19%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Diagnostyka 2.06B
NEUCA 12.82B
Voxel 556.98M
Synektik Spólka Akcyjna 623.20M
Celon Pharma 215.11M
Ryvu Therapeutics 97.57M
Selvita 359.79M
Centrum Medyczne ENEL-MED 762.83M
Revenue Rankings